La Jolla Light and San Diego Business Journal recently reported upon the approval of Qalsody (tofersen). See links below or the pdf file.
La Jolla Light: https://www.lajollalight.com/news/story/2023-05-06/la-jolla-scientists-help-develop-drug-approved-to-treat-genetic-als
San Diego Business Journal: https://www.sdbj.com/life-sciences/pharmaceuticals/fda-oks-new-als-drug/
Commentaires